Veracyte | VCYT - Debt


Veracyte reported $39.33M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
Agilent USD 3.36B 1000K Mar/2026
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 983.69M 5.77M Jun/2026
Bruker USD 1.82B 153.5M Jun/2026
Heron Therapeutics USD 149.65M 157K Sep/2024
Illumina USD 2.54B 9M Mar/2026
Intrexon USD 0 13.82M Jun/2024
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Laboratory Of America USD 7.24B 714.6M Mar/2026
Ligand Pharmaceuticals USD 451.98M 486K Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Siemens EUR 54.16B 2.3B Mar/2026
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Veracyte USD 39.33M 321K Mar/2026
Waters USD 5.57B 4.08B Mar/2026